ReviewPolymers2026
Toward Predictive Design of Lignocellulosic Mycelium-Bound Composites: A Process-Structure-Property Framework, Quantitative Synthesis, and Standardization Roadmap.
Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Agro-mycelial derived biocomposite for circular economy: technological developments, strategic insights, and market dynamics.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mycelium-bound composites (MBCs) have emerged as a promising class of biofabricated materials that integrate fungal hyphal networks with lignocellulosic substrates to form lightweight, biodegradable structures without synthetic adhesives. Despite rapid growth in the field, the current literature remains fragmented, with inconsistent methodologies and widely varying reported material properties. This review advances the field by moving beyond descriptive synthesis toward a quantitative and conceptual integration of existing studies. We systematically analyze how key fabrication variables-including fungal species, substrate composition, growth conditions, and post-processing parameters-govern density, porosity, and mechanical performance. A process-structure-property (PSP) framework is proposed to combine these relationships and explain discrepancies across studies. We highlight the dominant role of densification and moisture conditioning in determining compressive strength, often outweighing species-level effects. A comparative synthesis of reported data reveals significant variability in compressive strength (0.05-1.2 MPa) and elastic modulus, attributable to inconsistencies in sample preparation, testing protocols, and environmental conditioning. To address this, we identify critical gaps in standardization and propose actionable testing protocols and reporting guidelines for reproducibility. Furthermore, we assess the technology readiness level (TRL) of MBC systems and distinguish between laboratory-scale innovations and commercially viable processes. While hybridization strategies and biofunctional applications offer promising avenues, their maturity varies widely. This work provides a decision-oriented framework for MBC design and a roadmap for transitioning these materials from experimental systems to scalable, standardized, and application-ready biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.